Focus-out Glasses on Emmetropization in Chinese Children

Effect of Peripheral Focus-out Glasses on Emmetropization in Chinese Children Aged 6-8 Years: 2 Years Randomized Clinical Trial.

The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.

Study Overview

• Status: Active, not recruiting
• Conditions: Myopia; Hyperopia; Emmetropization
• Intervention / Treatment: Device: DEFOG glasses(peripheral focus-out glasses)

Detailed Description

Myopia is one of the most common eye diseases that cause visual impairment and blindness, and the high rate of myopia in young people is a major public health issue. Based on the clinical studies of optical defocusing to regulate eye growth and refractive changes through visual signal feedback, we hypothesize that early wearing of peripheral defocus glasses in children can slow down the process of emmetropization and even prevent the onset of myopia by producing more myopic defocusing. The aim of this study is to investigate whether wearing peripheral defocus glasses can effectively delay emmetropization in non-myopic children aged 6-8 years , and to further explore its effect on preventing the onset of myopia.

The study adopts a 2-year，single-centre, randomized, parallel-controlled trial with a non-blinded design. Subjects who pass the screening period will have their baseline data collected and will be assigned to the experimental or control groups according to the randomization principle. The experimental group will be fitted with Direct Emmetropia with Focus-out Glasses (hereafter referred to as DEFOG) to guide the emmetropization process. The control group will be given no treatment and will be a blank control. Baseline data including visual acuity, cycloplegic objective refraction, axis length, accommodation amplitude, strabismus examination, pupil size, choroidal thickness and peripheral retinal refraction will be measured when enrolled in the group and follow-up data will be measured at month 6, 12, 18 and 24. The primary interest of this study will be studied by comparing the difference in cycloplegic objective refraction changes between month 24 and baseline in the two groups of subjects.

• Study Type: Interventional
• Enrollment (Actual): 160
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Chenhao Yang; Phone Number: 8618017590866; Email: ychben@hotmail.com
• Study Contact Backup: Name: Li Shen; Phone Number: 8613816362715; Email: pearlee52@hotmail.com

Study Locations

• China
  • Shanghai
    • Shanghai, Shanghai, China, 201110
      • Children's Hospital of Fudan University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 6 years to 8 years (Child)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. Age: ≥6 and ≤8 years at enrollment.
2. At least one parent' s Spherical equivalent refraction≤-3.00D.
3. Spherical equivalent refractions (SERs) under cycloplegia: +0.50 to +1.50 diopters (D)
4. Astigmatism ≤1.00 D .
5. Anisometropia ≤1.00 D.
6. Best Corrected Visual Acuity (BCVA) : 1.0 or better
7. Provision of consent written by subject's legal guardian
8. Willing and able to participate in all required activities of the study

Exclusion Criteria:

1. Any of the following abnormalities on the ocular surface, such as trachoma, pemphigoid, chemical injury, heat burn, radiation injury, etc.
2. Eyelid abnormalities (e.g. entropion, ectropion, tumor, edema, blepharospasm, incomplete eyelid closure, severe trichiasis, severe ptosis) ,which affect eyelid function in either eye
3. Eye diseases such as strabismus, amblyopia, anisometropia, fundus diseases, and accommodation abnormality，etc.
4. Prior treatment of myopia control in either eye, including but not limited to drugs, orthokeratology, low-level red-light therapy, etc.
5. Noncompliance with measurement at enrollment.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: DEFOG group; Subjescts will wear DEFOG glasses(peripheral focus-out glasses).	Device: DEFOG glasses(peripheral focus-out glasses); Subjects in the intervention group will wear peripheral focus-out glasses ≧8 hours a day and ≧5 days a week.
No Intervention: Control group; Subjects in the control group will just be observed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Overall Changes of Cycloplegic Objective Refraction(spherical equivalent refraction, SER)(D)	Changes of cycloplegic objective refraction(i.e reflected by SER) from baseline till the 24th month (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER. Ciliary muscle paralysis will be performed by using 1% cyclopentanone eye drops, 2 doses in each eye, 2 doses 5 minutes apart. The optometry will be performed after 20 minutes of complete ciliary muscle paralysis (disappearance of pupil response to light or pupil diameter at least greater than 6 mm). SER is calculated by adding the sum of the sphere power with half of the cylinder power. Baseline data will be measured at the time of enrollment. Follow-up data will be measured on the 24th month from baseline. The 24th month data will be subtracted from the baseline data to obtain changes.	From baseline till the 24th month

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Changes of Axial Length(AL)(mm)	Changes of Axial Length (AL) between different follow-up time and the baseline time (only the right-eye data included).AL will be examined by IOL Master.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Axial Length (AL) (mm)	Axial Length (AL) at any follow-up time (only the right-eye data included).AL will be examined by IOL Master.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Amplitude of Accommodation (AMP)（D）	Amplitude of Accommodation (AMP) at any follow-up time (only the right-eye data included). AMP will be examined by lens test.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Visual Acuity	The Logarithmic Visual Acuity at any follow-up time (only the right-eye data included).	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Strabismus Examination（△）	Strabismus examination at any follow-up time by SYNOPTOPHORE.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Pupil size（mm）	Pupil size at any follow-up time (only the right-eye data included).	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Peripheral Retinal Refraction(D)	Peripheral Retinal Refraction at any follow-up time (only the right-eye data included). Peripheral Retinal Refraction will be examined by AUTO FUNDUS CAMERA.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Changes of Choroidal Thickness (ChT) （um）	Changes of Choroidal Thickness (ChT)between different follow-up time and the baseline time (only the right-eye data included). ChT will be examined by OPTICALCOHERENCETOMOGRAPHY.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Changes of Cycloplegic Objective Refraction(SER) (D)	Changes of cycloplegic objective refraction (i.e reflected by SER) different follow-up time and the baseline time (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER.	The 6th month, the 12th month and the 18th month from baseline
Cycloplegic Objective Refraction(SER)(D)	Cycloplegic objective refraction (i.e reflected by SER) any follow-up time (only the right-eye data included). Objective refraction data will be examined by AUTO REF/KERATOMETER.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
Myopia	Cycloplegic SER≦-0.50D at any follow-up time. Objective refraction data will be examined by AUTO REF/KERATOMETER.	The 6th month, the 12th month, the 18th month and the 24th month from baseline
The percentage of participants with fast myopic shift	The percentage of participants with fast myopic shift over 2 years(only the right-eye data included). The fast myopic shift is defined as cycloplegic objective refraction (i.e reflected by SER) myopic shift of at least 1.00 D. Objective refraction data will be examined by AUTO REF/KERATOMETER.	From baseline till the 24th month
Corneal curvature(D) or radius of curvature(mm)	Corneal curvature or radius of curvature(only the right-eye included). They can be interconverted. Data will be examined by AUTO REF/KERATOMETER.	The 6th month, the 12th month, the 18th month and the 24th month from baseline

Collaborators and Investigators

• Sponsor: Children's Hospital of Fudan University

Study record dates

Study Major Dates

• Study Start (Actual): March 23, 2023
• Primary Completion (Estimated): March 31, 2025
• Study Completion (Estimated): March 31, 2025

Study Registration Dates

• First Submitted: January 10, 2023
• First Submitted That Met QC Criteria: January 10, 2023
• First Posted (Actual): January 19, 2023

Study Record Updates

• Last Update Posted (Actual): April 17, 2024
• Last Update Submitted That Met QC Criteria: April 15, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Eye Diseases; Refractive Errors; Hyperopia
• Other Study ID Numbers: DEFOG

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No